Technology

Cocrystal Pharma

$1.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.31%) Today
-$0.01 (-0.66%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell COCP and other stocks, options, and ETFs commission-free!

About COCP

Cocrystal Pharma, Inc. Common Stock, also called Cocrystal Pharma, is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA. The listed name for COCP is Cocrystal Pharma, Inc. Common Stock.

CEO
Gary L. Wilcox
Employees
11
Headquarters
Bothell, Washington
Founded
2014
Market Cap
100.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.50M
High Today
$1.59
Low Today
$1.50
Open Price
$1.59
Volume
1.65M
52 Week High
$3.04
52 Week Low
$0.4736

Collections

COCP Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 12, After Hours

You May Also Like

APG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure